日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Loss of LncRNA DUXAP8 synergistically enhanced sorafenib induced ferroptosis in hepatocellular carcinoma via SLC7A11 de-palmitoylation

LncRNA DUXAP8 的缺失通过 SLC7A11 去棕榈酰化协同增强索拉非尼诱导的肝细胞癌铁死亡

Zhehao Shi, Zhiming Li, Bin Jin, Wen Ye, Luhui Wang, Sina Zhang, Jiuyi Zheng, Zixia Lin, Bo Chen, Fangting Liu, Baofu Zhang, Xiwei Ding, Zhen Yang, Yunfeng Shan, Zhengping Yu, Yi Wang, Jicai Chen, Qiang Chen, Lewis R Roberts, Gang Chen

Synergistic Effect of Lenvatinib and Chemotherapy in Hepatocellular Carcinoma Using Preclinical Models

使用临床前模型研究仑伐替尼与化疗对肝细胞癌的协同作用

Mingxun Wang #, Xinfei Yao #, Zhiyuan Bo #, Jiuyi Zheng, Haitao Yu, Xiaozai Xie, Zixia Lin, Yi Wang, Gang Chen, Lijun Wu

CAFs-derived SCUBE1 promotes malignancy and stemness through the Shh/Gli1 pathway in hepatocellular carcinoma

CAFs 衍生的 SCUBE1 通过 Shh/Gli1 通路促进肝细胞癌的恶性程度和干性

Jungang Zhao, Rizhao Li, Jiacheng Li, Ziyan Chen, Zixia Lin, Baofu Zhang, Liming Deng, Gang Chen, Yi Wang

The LipoxinA4 receptor agonist BML-111 ameliorates intestinal disruption following acute pancreatitis through the Nrf2-regulated antioxidant pathway

LipoxinA4 受体激动剂 BML-111 通过 Nrf2 调节的抗氧化途径改善急性胰腺炎后的肠道紊乱

Zhehao Shi, Yi Wang, Wen Ye, Zixia Lin, Tuo Deng, Tan Zhang, Jungang Zhao, Yifan Tong, Yunfeng Shan, Gang Chen